Triheptanoin

DB11677

small molecule approved investigational

Deskripsi

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation.L14612 In clinical trials, patients with long chain fatty acid oxidation disorders (lc-FAODs) treated with triheptanoin are less likely to develop hypoglycemia, cardiomyopathy, rhabdomyolysis, and hepatomegaly.A214812,A214817 Complications in lc-FAOD patients are reduced from approximately 60% to approximately 10% with the addition of triheptanoin.A214817

Triheptanoin was granted FDA approval on 30 June 2020.L14612

Struktur Molekul 2D

Berat 428.61
Wujud liquid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Due to multiple peak concentrations of the heptanoate metabolite, the half life of triheptanoin could not be determined.[L14612]
Volume Distribusi -
Klirens (Clearance) A single dose of 0.3 g/kg results in a mean apparent clearance of 6.05 L/h/kg for heptanoate.[L14612] A single dose of 0.4 g/kg results in a mean apparent clearance of 4.31 L/h/kg for heptanoate.[L14612]

Absorpsi

A single 0.3 g/kg dose of triheptanoin reaches a Cmax of 178.9 µmol/L, with a Tmax 0.5 h, and an AUC of 336.5 µmol\*h/L.L14612 A single 0.4 g/kg dose of triheptanoin reaches a Cmax of 259.1 µmol/L, with a Tmax 0.8 h, and an AUC of 569.1 µmol\*h/L.L14612

Metabolisme

Triheptanoin is hydrolysed to heptanoate, which can be further metabolized to ?-hydroxypentanoate or ?-hydroxybutyrate.L14612

Rute Eliminasi

Triheptanoin is minimally eliminated in the urine.L14612

Interaksi Makanan

1 Data
  • 1. Take with food. Take triheptanoin with food, liquid, or formula.

Interaksi Obat

1 Data
Orlistat Orlistat can cause a decrease in the absorption of Triheptanoin resulting in a reduced serum concentration and potentially a decrease in efficacy.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 31778232
    Wehbe Z, Tucci S: Therapeutic potential of triheptanoin in metabolic and neurodegenerative diseases. J Inherit Metab Dis. 2020 May;43(3):385-391. doi: 10.1002/jimd.12199. Epub 2019 Dec 12.
  • PMID: 26547562
    Roe CR, Brunengraber H: Anaplerotic treatment of long-chain fat oxidation disorders with triheptanoin: Review of 15 years Experience. Mol Genet Metab. 2015 Dec;116(4):260-8. doi: 10.1016/j.ymgme.2015.10.005. Epub 2015 Oct 24.
  • PMID: 19745557
    van der Vusse GJ: Albumin as fatty acid transporter. Drug Metab Pharmacokinet. 2009;24(4):300-7. doi: 10.2133/dmpk.24.300.

Contoh Produk & Brand

Produk: 2 • International brands: 1
Produk
  • Dojolvi
    Liquid • 100 % w/w • Oral • Canada • Approved
  • Dojolvi
    Liquid • 0.96 g/1mL • Oral • US • Approved
International Brands
  • Dojolvi

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul